Therapy Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Therapy Name Pimicotinib
Synonyms
Therapy Description

Pimjetmi (pimicotinib) selectively inhibits CSF1R, potentially leading to inhibition of tumor cell proliferation, enhanced T cell immune response, and antitumor activity (J Clin Oncol 41, 2023 (suppl 16; abstr 11559, PMID: 41796601). Pimjetmi (pimicotinib) is FDA-approved for use in patients with symptomatic tenosynovial giant cell tumor (FDA.gov).

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Drug Name Trade Name Synonyms Drug Classes Drug Description
Pimicotinib Pimjetmi ABSK 021|ABSK-021|CSF-1R Inhibitor ABSK021|ABSK021 CSF1R Inhibitor 28 Pimjetmi (pimicotinib) selectively inhibits CSF1R, potentially leading to inhibition of tumor cell proliferation, enhanced T cell immune response, and antitumor activity (J Clin Oncol 41, 2023 (suppl 16; abstr 11559, PMID: 41796601). Pimjetmi (pimicotinib) is FDA-approved for use in patients with symptomatic tenosynovial giant cell tumor (FDA.gov).

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT05804045 Phase III Pimicotinib Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor Active, not recruiting USA | POL | NLD | ITA | ESP | CAN 1
NCT07499362 Phase II Pimicotinib Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) Recruiting 1
NCT04192344 Phase I Pimicotinib A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK021 in Patients With Advanced Solid Tumor Recruiting USA 1


Additional content available in Icon for CKB-BoostCKB BOOST